View the case of a 60-year-old male patient who was diagnosed with pulmonary embolism and a large TIT, and see how he was treated by percutaneous thrombectomy.

The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.

Find out more about how the authors managed a 53-year old male with ischemic cardiomyopathy, EF 25 %, and calcified 3-vessel disease ! 

Paris, France 17 May 2022 – On the 19th of May the Andreas Grüntzig Ethica Award, the highest honour in the interventional cardiology community, will be awarded at EuroPCR 2022 to the Nurses and Allied Professionals community in recognition of the essential role they play in...

Paris, France. 17 May 2022. May 17th is World Hypertension Day whose theme “Measure Your Blood Pressure Accurately, Control It, Live Longer” is aimed at increasing awareness of hypertension worldwide. Besides awareness, effective control of hypertension remains low in the general population. At EuroPCR 2022, the...

Paris, May 2022: A festive EuroPCR 2022 – the World Leading Course in interventional cardiovascular medicine – took place again in person, after a hiatus of 2 years caused by the COVID19 pandemic. The new blended EuroPCR format attracted 11,000 participants in person and online with...

Paris, France. 19 May 2022. We CARE, a joint initiative of PCR and Stent – Save a Life!, dedicated to restoring faith in cardiovascular healthcare and increasing awareness of the importance of timely and accessible treatment, is presenting a first study at EuroPCR 2022: a UK...

This freshly updated chapter extensively describes percutaneous tools and techniques to assess and treat challenging calcified lesions.

The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.

This report builds up the evidence on the relevance of extra-valvular cardiac damage staging / involvement as a main predictor of adverse events in patients with VHD undergoing intervention, either surgical or percutaneous.

This study investigated the short-term safety and efficacy of the new valve ACURATE neo2 in comparison to the first neo model in a real-world population.

This study aimed at investigating the impact of commissural misalignment on clinical outcomes and hemodynamic performance of balloon-expandable devices.

As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.

This year’s PCR Tokyo Valves took the form of a dedicated series of 6 live webinars. They took place from September to December 2022, last one hour each, and are all in English. They address a broad range of issues in structural...

The EuroIntervention Journal is pleased to announce its 2021 Impact Factor: 7.728 (2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)

With this result, we confirm last year's progression and we are proud to be listed 2nd amongst interventional cardiology journals. 

Watch the 1st of #PCRtokyo 2022’s six live webinars about ‘The importance of hemodynamic performance in transcatheter aortic valves’.

The CASTLE trial is a randomised multicentre prospective non-inferiority trial comparing ultra-thin strut bioresorbable polymer and thin strut durable polymer drug eluting stents implanted with intracoronary imaging guidance.

DEFINITION II was a randomised control trial comparing PCI in complex bifurcation lesions using a two-stent technique versus a provisional stenting strategy. At one year follow-up, a two-stent technique was superior to a provisional approach in true complex bifurcations. Here, the authors present the 3-year clinical outcomes...